Does LORLATINIB Cause Dysarthria? 39 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 39 reports of Dysarthria have been filed in association with LORLATINIB (Lorbrena). This represents 0.7% of all adverse event reports for LORLATINIB.
39
Reports of Dysarthria with LORLATINIB
0.7%
of all LORLATINIB reports
1
Deaths
15
Hospitalizations
How Dangerous Is Dysarthria From LORLATINIB?
Of the 39 reports, 1 (2.6%) resulted in death, 15 (38.5%) required hospitalization, and 2 (5.1%) were considered life-threatening.
Is Dysarthria Listed in the Official Label?
Yes, Dysarthria is listed as a known adverse reaction in the official FDA drug label for LORLATINIB.
What Other Side Effects Does LORLATINIB Cause?
Death (1,050)
Neoplasm progression (633)
Off label use (394)
Weight increased (306)
Hallucination (290)
Blood cholesterol increased (281)
Dyspnoea (223)
Oedema peripheral (198)
Oedema (195)
Fatigue (188)
What Other Drugs Cause Dysarthria?
OLANZAPINE (900)
QUETIAPINE (669)
PREGABALIN (618)
AMLODIPINE (553)
GABAPENTIN (548)
METFORMIN (540)
METHOTREXATE (536)
DIAZEPAM (512)
ASPIRIN (495)
LORAZEPAM (483)
Which LORLATINIB Alternatives Have Lower Dysarthria Risk?
LORLATINIB vs LORMETAZEPAM
LORLATINIB vs LORNOXICAM
LORLATINIB vs LOSARTAN
LORLATINIB vs LOSARTAN\LOSARTAN
LORLATINIB vs LOTEPREDNOL ETABONATE